HRTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Heron Therapeutics Inc (HRTX) is not a good buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance is weak, and there are no significant positive catalysts or trading signals to support an immediate investment.
The technical indicators for HRTX are bearish. The MACD is below 0 and negatively expanding, the RSI is neutral at 23.818, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 1.039, S2: 0.963), suggesting further downside potential.
NULL. There are no recent news, significant insider or hedge fund activity, or congress trading data to act as a positive catalyst.
and is expected to perform poorly in the short term (-0.58% next day, -3.61% next month).
In Q4 2025, HRTX reported a revenue decline of -0.47% YoY to $40.59M, net income dropped by -180.64% YoY to -$2.95M, and EPS fell by -200% YoY to -$0.02. Gross margin also declined to 72.61%, down -3.08% YoY.
No recent analyst ratings or price target changes available for HRTX.
